X

Health Care

Summit Therapeutics reports loss of $0.04 per share for Q1

Summit Therapeutics (NASDAQ: SMMT) reported a narrower-than-expected loss for the first quarter of 2019 while revenues missed estimates. The stock…

CymaBay Therapeutics stock drops to 2-year low after bitter NASH study data

CymaBay Therapeutics (NASDAQ: CBAY) stock fell to a two-year low of $4.82 on Tuesday after disappointing nonalcoholic steatohepatitis (NASH) trial…

Advaxis’ revenue declines in Q2 as Amgen terminaties collaboration agreement

Advaxis (NASDAQ: ADXS) reported that Q2 revenue decreased to $1.2 million from $1.7 million in the prior year quarter. The…

Earnings preview: Advaxis stock treading near an all-time low ahead of Q2 results

Late-stage biotech firm Advaxis, Inc. (NASDAQ: ADXS) is scheduled to report second-quarter financial results on June 10, Monday, after the…

Tilray stock heads downward on doubts of cannabis risks

Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. The stock has been on a downward…

What’s in store for top pharma stocks this year

The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note,…

CVS’ stock gains as company lays out growth strategy

CVS Health’s (NYSE: CVS) shares were up 3.2% in afternoon hours as the company outlined its growth strategy and reaffirmed…

WeedMD posts wider loss in Q1 but revenue soars 192%

Medical-grade cannabis producer WeedMD Inc. reported a wider loss in the first quarter of 2019 due to higher costs and…

Veeva Systems reports stellar Q1 earnings, outlook beat estimates

Veeva Systems (NYSE: VEEV) reported yet another solid earnings beating analyst estimates. The company also raised its full-year outlook and…

Looming opioid epidemic calls for stricter drug regulation

Though the healthcare industry is slowly waking up to the hazards of opioid-based prescription drugs, their sale continues unabated across…

Soliton spikes over 50% on its decision to proceed with cellulite trials

Shares of Soliton Inc. (NASDAQ: SOLY) jumped over 50% during the morning trade on Wednesday after the medical device company…

Charlotte’s Web Holdings retains full-year outlook; to delist from CSE

Charlotte’s Web Holdings (CSE: CWEB; OTCQX: CWBHF) first-quarter results came in line with the preliminary guidance provided earlier this month.…

Earnings Preview: Charlotte’s Web to report solid Q1 results aided by multiple tailwinds

Charlotte's Web Holdings (CSE: CWEB; OTCQX: CWBHF) is planning to report its first-quarter results tomorrow after the bell. The company…

Novartis’ one-time gene therapy for spinal muscular atrophy gets FDA nod

Picture Courtesy: Novartis Zolgensma, a gene-based treatment from Novartis (NYSE: NVS) for the treatment of spinal muscular atrophy that affects…

Centene stock spikes as activist investor Third Point pushes for its sale

Shares of Centene Corp (NYSE: CNC) shot up over 3% on average volume on Friday, after it was revealed that…

Medtronic tops expectations on Q4 results

Medtronic plc (NYSE: MDT) reported revenue and earnings for the fourth quarter of 2019 that topped market expectations. Shares rose…

Affimed’s stock tanks as company announces termination of cancer program

Affimed NV (NASDAQ: AFMD) reported first-quarter 2019 earnings results and announced its plans to terminate its cancer program while focusing…

Canopy Growth names Constellation Brands veteran as acting CFO

Image by Rex Medlen from Pixabay Shares of Canopy Growth Corporation (NYSE: CGC) gained over 2% on Tuesday after the…

Medtronic to announce Q4 results amidst pacemaker crisis

Medtronic (NYSE: MDT) is scheduled to report fourth-quarter 2019 financial results on Thursday, May 23, before the regular trading hours.…

Bio-Path’s stock tanks as company delivers loss for Q1

Bio-Path Holdings Inc.’s (NASDAQ: BPTH) shares were down 3.2% in morning hours on Thursday after the company reported its first…

Titan Pharmaceuticals posts wider-than-expected Q1 loss

Titan Pharmaceuticals (TTNP) reported a wider loss in the first quarter of 2019 due to lower revenues and higher operating…